Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: Boston MA, New Hyde Park NY, New York NY,
Sponsor: Jubilant DraxImage Inc.
Sex: All
Age: 1+
Code: NCT03561259
Phase 2, Recruiting
Dual Mobility Acetabular Cups in Revision TJA
for
Dislocation, Hip
Location: Philadelphia PA
Sponsor: Rush University Medical Center
Sex: All
Age: 18+
Code: NCT04090359
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase 3, Recruiting
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
for
Uterine Fibroid
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 18+
Code: NCT06705075
Phase 2, Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Boston MA, Springfield MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
for
Heart Failure With Preserved Ejection Fraction
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05138575
Phase 2, Recruiting
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Durham NC, Pittsburgh PA
Sponsor: Ethicon, Inc.
Sex: Female
Age: 21+
Code: NCT04829175
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML
for
Leukemia, Myeloid, Acute
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05945849
Phase 1, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Boston MA, New Haven CT, Great Neck NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
SLV-154 Treatment of Advanced Cancers
for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Solve Therapeutics
Sex: All
Age: 12+
Code: NCT06771219
Phase 1, Recruiting
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
for
Glioblastoma, Recurrent Glioblastoma,
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06613841
Early Phase 1, Recruiting
Mapping Disease Pathways for Biliary Atresia
for
Biliary Atresia
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 0+
Code: NCT03273049
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)